In vivo study | In mice breathing air and oxygen, efaprox Iral and oxygen respiration reduced the radiobiological hypoxia fraction of EMT6 tumors from 24% to 9%, increasing the tumor response to radiation. Efaproxir and oxygen increased growth delay to 5.7 days, which was 2.4 days (71%) higher than Carboplatin alone and 2.1 days (57%) higher than Carboplatin and oxygen. Thus, efaproxir and oxygen respiration increased the tumor suppressor effect of 100 mg/kg and 150 mg/kg carboplatin, but did not increase the toxicity of 100 mg/kg carboplatin in mice breathing air. In C3H mice with RIF-1 tumors, efaproxir significantly increased tumor oxygenation, from 8.4 to 43.4 Hg within 5 days, with the maximum increase occurring at 22-31 minutes post-treatment. In C3H mice with RIF-1 tumors, efaprox IR plus oxygen plus radiation resulted in tumor growth inhibition that was significantly different from radiation plus oxygen from Day 3 to day 5. |